MARS imaging and the arrival of 3D color X-rays
November 28, 2018
X-Ray
From the November 2018 issue of HealthCare Business News magazine
In time, data processing techniques should catch up and allow a whole body scan. “The first human trials will be used to demonstrate some of the applications of MARS scanning that have already been researched using our preclinical system, for example, looking at early biochemical changes in cartilage,” said Butler.
For him, the most surprising thing to come out of this project has been how well the raft of skills from a multinational, interdisciplinary team complement each other. Over 50 people including physicists, clinicians, scientists and engineers, are currently working on the commercialization of the scanner and research into clinical applications. According to Butler, “It is this interdisciplinary approach which has driven the success of the project, and allowed an innovation from New Zealand to make waves on a global scale.”
About the author: Hannah Prebble is a clinical applications researcher for MARS Bioimaging Ltd. in Christchurch, New Zealand.
Back to HCB News
In time, data processing techniques should catch up and allow a whole body scan. “The first human trials will be used to demonstrate some of the applications of MARS scanning that have already been researched using our preclinical system, for example, looking at early biochemical changes in cartilage,” said Butler.
For him, the most surprising thing to come out of this project has been how well the raft of skills from a multinational, interdisciplinary team complement each other. Over 50 people including physicists, clinicians, scientists and engineers, are currently working on the commercialization of the scanner and research into clinical applications. According to Butler, “It is this interdisciplinary approach which has driven the success of the project, and allowed an innovation from New Zealand to make waves on a global scale.”
Reveal 35C: spectral bedside imaging, no extra dose, now available in the EU
KA Imaging’s Reveal 35C detector, currently available as an upgrade solution in the US and selected geographies, can now be sold in the European Union. The detector recently obtained the CE Mark. Contact us at sales@kaimaging.com to book a free demo.
About the author: Hannah Prebble is a clinical applications researcher for MARS Bioimaging Ltd. in Christchurch, New Zealand.
Back to HCB News
You Must Be Logged In To Post A CommentRegisterRegistration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now! |
|
